These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21064591)

  • 1. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; anaphylactogenic properties of typhus fever vaccines and equine encephalomyelitis vaccine.
    COULSON EJ; STEVENS H
    Fed Proc; 1946; 5(1 Pt 2):245. PubMed ID: 21064591
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; anaphylactogenic properties of typhus fever vaccines and equine encephalomyelitic vaccines.
    COULSON EJ; STEVENS H
    J Immunol; 1946 Aug; 53():321-42. PubMed ID: 20998816
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; skin sensitivity following the subcutaneous inoculation of typhus vaccines in humans.
    PLOTZ H
    Fed Proc; 1946; 5(1 Pt 2):252. PubMed ID: 21064608
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; skin-sensitivity following the subcutaneous inoculation of typhus vaccines in man.
    PLOTZ H
    J Immunol; 1946 Aug; 53():315-9. PubMed ID: 21065180
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks.
    PLOTZ H
    J Immunol; 1946 Aug; 53():315-53. PubMed ID: 20998815
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum albumine as a protective rather than nutritive growth factor in bacteriological media.
    DAVIS BD; DUBOS RJ
    Fed Proc; 1946; 5(1 Pt 2):246. PubMed ID: 20984587
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; a study to determine whether chick-embryo yolk-sac vaccines contain sufficient egg proteins to cause severe systemic reactions if given to egg-sensitive individuals.
    STULL A
    J Immunol; 1946 Aug; 53():343-53. PubMed ID: 20998817
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; a study to determine whether chick yolk sac vaccines contained sufficient egg proteins to cause severe systemic reactions if given to egg-sensitive individuals.
    STULL A
    Fed Proc; 1946; 5(1 Pt 2):254. PubMed ID: 21064614
    [No Abstract]   [Full Text] [Related]  

  • 9. The quantitative estimation of egg and chicken proteins in equine encephalomyelitis vaccine.
    ENGEL LL; RANDALL R
    Fed Proc; 1947; 6(1):426. PubMed ID: 20343905
    [No Abstract]   [Full Text] [Related]  

  • 10. The quantitative estimation of egg and chicken proteins in equine encephalomyelitis vaccines.
    ENGEL LL; RANDALL R
    J Immunol; 1947 Apr; 55(4):325-9. PubMed ID: 20294485
    [No Abstract]   [Full Text] [Related]  

  • 11. [Associated vaccine against typhus and Q-fever and the possibility of decreased reactogenic properties of the vaccine against Q-fever].
    GOLINEVICH EM; GENIG VA
    Vopr Virusol; 1961; 6():728-32. PubMed ID: 13899955
    [No Abstract]   [Full Text] [Related]  

  • 12. The preparation and properties of a purified equine encephalomyelitis vaccine.
    RANDALL R; MILLS JW; ENGEL LL
    J Immunol; 1947 Jan; 55(1):41-52. PubMed ID: 20285155
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response of horses to Japanese equine encephalomyelitis mouse brain vaccine.
    BURNS KF
    Am J Vet Res; 1951 Apr; 12(43):106-9. PubMed ID: 14829760
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of Cox-type vaccine on louse-borne typhus fever; an account of 61 cases of naturally occurring typhus fever in patients who had previously received one or more injections of Cox-type vaccine.
    ECKE RS; GILLIAM AG
    Am J Trop Med Hyg; 1945 Nov; 25():447-62. PubMed ID: 21010811
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of Cox-type vaccine in the prevention of naturally acquired louse-borne typhus fever.
    GILLIAM AG
    Am J Hyg; 1946 Nov; 44(3):401-10. PubMed ID: 20274592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic encephalomyelopathy after anti-typhus-paratyphus-tetanus vaccination].
    RUEDE M
    Ther Umsch; 1953 Feb; 9(11):162-5. PubMed ID: 13077427
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on commercial typhus vaccines. I. The antigenic constituents of commercial epidemic typhus vaccine.
    CHAMBERS LA; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):451-7. PubMed ID: 14794908
    [No Abstract]   [Full Text] [Related]  

  • 18. On the preparation of vaccine against typhus fever and the experiences gathered therewith.
    PONDMAN A
    Antonie Van Leeuwenhoek; 1944-1945; 10(1-2):57-66. PubMed ID: 20990859
    [No Abstract]   [Full Text] [Related]  

  • 19. On the preparation of vaccine against typhus fever and the experiences gathered therewith.
    PONDMAN A
    Rev Belg Pathol Med Exp; 1951 Nov; 21(3):299-308. PubMed ID: 14921203
    [No Abstract]   [Full Text] [Related]  

  • 20. Venezulean equine encephalomyelitis; laboratory aspects of fourteen human cases following vaccination and attempts to isolate the virus from the vaccine.
    SMITH DG; MAMAY HK; MARSHALL RG; WAGNER JC
    Am J Hyg; 1956 Mar; 63(2):150-64. PubMed ID: 13302205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.